JPRN-UMIN000008344已完成未知
The impact of DPP-4 inhibitor on daily glucose profile and coronary plaque character in diabetic patients with coronary artery disease - the IMpact of sitAgliptin on daily Glucose profIle and coroNary plaquE character in diabetic patients with coronary artery disease:IMAGINE-KOBE study
Division of Cardiovascular Medicine, Kobe University Graduate School of Medicine0 个研究点目标入组 44 人开始时间: 2012年7月4日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 44
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients meeting one of the following conditions will be excluded: 1) poor control:HbA1c(NGSP)>8.5, or under treatment of diabetes, or type 1 diabetes 2)severe liver dysfunction 3)severe renal dysfunction (Cre 1.3 mg/dL) 4)severe heart failure) (NYHA/New York Heart Association stage III or severer) 5)Malignancies or other diseases with poor prognosis 6) pregnant, lactating, and possibly pregnant women and those planning to become pregnant 7) past medical history of hypersensitivity to investigational drugs 8) judged as ineligible by clinical investigators
研究者
相似试验
尚未招募
4 期
Exploratory study of DPP-4 inhibitor on glycemic control and organ protection in type2 diabetic patientsJPRN-UMIN000012171Tokyo Jikei University School of Medicine Kashiwa Hospital60
Unknown
不适用
Glucose Variability With DPP-4 InhibitionType 2 DiabetesNCT01751321Research Clinical Centre of the Russian Railways, JSC50
已完成
不适用
Effect of DPP-4 inhibitor on insulin therapy for patients with type 2 diabetesType 2 diabetesJPRN-UMIN000006470Jikei University School of Medicine Kashiwa Hospital20
已完成
不适用
The efficacy of DPP-4 inhibitors and alpha glucosidase inhibitors for type 2diabetesPatients with type 2 diabetesJPRN-UMIN000011788ational Center for Global Health and Medicine15
已完成
不适用
Effect of DPP4 inhibitor or alpha-glucosidase inhibitor on postprandial lipemia and endothelial dysfunctioJPRN-UMIN000012738Okayama Rosai Hospital10